Skip to main content
Premium Trial:

Request an Annual Quote

Corning Subsidiary to Manufacture Advion s Electrospray Chip for Mass Spec

NEW YORK, Sept. 20 - Corning subsidiary IntelliSense has signed a definitive 30 month deal to manufacture Advion BioScienes’ Electrospray Ionization Chip, a microelectro mechanical systems (MEMS) device for mass spectrometry.

Advion’s ESI Chip uses microfabricated electrospray nozzles to deliver a liquid sample into a mass spectrometer. The ESI Chip is designed to increase the sensitivity and stability for mass spectrometry analysis. The chip also reduces the amount of sample that it is required, ultimately helping to drive down costs, Intellisense said.

"When we decided to ramp-up production, we saw that we needed an experienced, ISO-certified manufacturing partner,” Tom Kurz, chief operating officer of Advion BioSciences, said in a statement released Wednesday.

“IntelliSense's depth of MEMS knowledge is exactly what we needed to ensure a high-quality product,” he added.

Advion BioSciences of Ithaca, NY, develops chip-based technologies for bioanalytical services. The ESI Chip is one of the few systems to combine mass spectrometry and microfluidics for high-throughput analysis in proteomics, genomics, and drug discovery.

Based in Wilmington, Mass., IntelliSense specializes in manufacturing products for the life science industry.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.